Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Jens G Lohr

Determining the mutational landscape of circulating multiple myeloma cells

Multiple myeloma and immunoproliferative diseases

Pathology

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Thymus Prostate Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Antoinette Stroup

PATTERNS OF CARE/QUALITY OF CARE STUDY : DIAGNOSIS YEAR 2014

Multiple myeloma and immunoproliferative diseases Leukaemia Colorectum

Conor C Lynch

Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Wei Gu

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Colorectum

Kenneth C. Anderson

SPORE in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Oliver W. Press

CD38 Pretargeted Radioimmunotherapy for Myeloma

Multiple myeloma and immunoproliferative diseases